GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Global Inc (OTCPK:CBGL) » Definitions » EBITDA Margin %

Cannabis Global (Cannabis Global) EBITDA Margin % : -0.25% (As of May. 2022)


View and export this data going back to 2008. Start your Free Trial

What is Cannabis Global EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Cannabis Global's EBITDA for the three months ended in May. 2022 was $-0.00 Mil. Cannabis Global's Revenue for the three months ended in May. 2022 was $0.79 Mil. Therefore, Cannabis Global's EBITDA margin for the quarter that ended in May. 2022 was -0.25%.


Cannabis Global EBITDA Margin % Historical Data

The historical data trend for Cannabis Global's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Global EBITDA Margin % Chart

Cannabis Global Annual Data
Trend Aug12 Aug13 Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -12,977.78 -37.10

Cannabis Global Quarterly Data
Aug17 Nov17 Feb18 May18 Aug18 Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 97.34 -278.41 299.65 420.26 -0.25

Competitive Comparison of Cannabis Global's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Global's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Global's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Global's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Cannabis Global's EBITDA Margin % falls into.



Cannabis Global EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Cannabis Global's EBITDA Margin % for the fiscal year that ended in Aug. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Aug. 2021 )/Revenue (A: Aug. 2021 )
=-0.594/1.601
=-37.10 %

Cannabis Global's EBITDA Margin % for the quarter that ended in May. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: May. 2022 )/Revenue (Q: May. 2022 )
=-0.002/0.792
=-0.25 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Global  (OTCPK:CBGL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Cannabis Global EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Cannabis Global's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Global (Cannabis Global) Business Description

Traded in Other Exchanges
N/A
Address
520 S. Grand Avenue, Suite 320, Los Angeles, CA, USA, 90071
Cannabis Global manufactures and distributes various cannabis products via its majority ownership of Natural Plant Extract, Inc is developing the Ethos Comply Bag, and generally conducts research and development in the areas of hemp, cannabis and consumer food goods. The company also have an active research and development program primarily focused on creating and commercializing engineered technologies that deliver hemp extracts and cannabinoids to the human body. Its product includes cannabis flower packaged in various weights, cannabis Pre-rolls, cannabis edible products.
Executives
Jim L. Riley director C/O CANNABIS GLOBAL INC., 520 S GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Ghs Investments, Llc 10 percent owner 0830 SOUTH EASTERN AVENUE, #124-376, LAS VEGAS NV 89123
Hymers Iii R. Leslie director, 10 percent owner 520 S GRAND AVENUE, STE 320, LOS ANGELES CA 90071
Arman Tabatabaei director, officer: CEO, CFO 520 SOUTH GRAND AVENUE, SUITE 320, LOS ANGELES CA 90071
Lauderdale Holdings, Llc director, 10 percent owner, officer: CEO/President/CFO 1919 NW 19 STREET, FT LAUDERDALE FL 33311
Harmel S Rayat 10 percent owner 700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1
David A Gamache director, officer: SECRETARY/TREASURER/CFO 3905 NATIONAL DRIVE, SUITE 110, BURTONSVILLE MD 20866
Meetesh V Patel director, officer: PRESIDENT/CEO 8775 CENTRE PARK DRIVE, # 210, COLUMBIA MD 21045
Pattiann Hiranandani director 3905 NATIONAL DRIVE, BURTONSVILLE MD 20866

Cannabis Global (Cannabis Global) Headlines